Efficacy and safety of low-dose ketoconazole (50 mg) to reduce the cost of cyclosporine in renal allograft recipients.
Abraham
M A
MA
Department of Nephrology, Christian Medical College and Hospital, Vellore, India.
Thomas
P P
PP
John
G T
GT
Job
V
V
Shankar
V
V
Jacob
C K
CK
D000328:Adult; D019540:Area Under Curve; D003365:Costs and Cost Analysis; D016572:Cyclosporine / Q000191:economics* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000191:economics* / Q000627:therapeutic use*; D007654:Ketoconazole / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000191:economics / Q000276:immunology* / Q000401:mortality; D008297:Male; D015996:Survival Rate; D013997:Time Factors; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D007654:Ketoconazole